^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

EGFR exon 21 mutation

i
Other names: EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Entrez ID:
EGFR exon 21 mutation
Non Small Cell Lung Cancer
erlotinib + ramucirumab
Sensitive
:
B
EGFR exon 21 mutation
Non Small Cell Lung Cancer
icotinib
Sensitive
:
B
EGFR exon 21 mutation
Non Small Cell Lung Cancer
gefitinib
Sensitive
:
C2
EGFR exon 21 mutation
Non Small Cell Lung Cancer
erlotinib
Sensitive
:
C2
EGFR exon 21 mutation
Non Small Cell Lung Cancer
bevacizumab + osimertinib
Resistant
:
C2
EGFR exon 21 mutation
Non Small Cell Lung Cancer
erlotinib + anlotinib
Sensitive
:
C3
EGFR exon 21 mutation
Non Small Cell Lung Cancer
PD-L1 inhibitor
Sensitive
:
C3
EGFR exon 21 mutation
Non Small Cell Lung Cancer
PD1 inhibitor
Sensitive
:
C3
EGFR exon 21 mutation
Lung Adenocarcinoma
erlotinib
Sensitive
:
C3
EGFR exon 21 mutation
Non Small Cell Lung Cancer
dacomitinib
Sensitive
:
C3
EGFR exon 21 mutation
Non Small Cell Lung Cancer
Tyrosine kinase inhibitor
Sensitive
:
C3
EGFR exon 21 mutation
Non Small Cell Lung Cancer
afatinib
Sensitive
:
C3
EGFR exon 21 mutation
Non Small Cell Lung Cancer
durvalumab
Sensitive
:
C3
EGFR exon 21 mutation
Non Small Cell Lung Cancer
FCN-411
Sensitive
:
C3
EGFR exon 21 mutation
Small Cell Lung Cancer
gefitinib
Sensitive
:
C4
EGFR exon 21 mutation
Lung Adenocarcinoma
dacomitinib
Sensitive
:
C4